Gao, Y., Ping, L., Wu, J., Huang, Y., Zhou, H., Feng, R., Huang, H. (2025). Long-term outcomes of a novel initial regimen: Rituximab plus pegylated interferon α-2b in untreated advanced indolent B-cell lymphoma – 5-year follow-up of the ripple study. Blood. https://doi.org/10.1182/blood-2025-5375